Talia Weinstein

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

Mona Boaz, Shmuel Smetana, Talia Weinstein et al. · The Lancet · 2000 · 1K citations

Urology, Renal Disease, Renal Function +11

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

VEGF Expression in Hypoxia and Hyperglycemia

Byung‐Soo Kim, Jun Chen, Talia Weinstein et al. · Journal of the American Society of Nephrology · 2002 · 86 citations

Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin‐Angiotensin‐Aldosterone System Inhibition Therapy

Gil Chernin, Amir Gal‐Oz, Eyal Ben–Assa et al. · Clinical Cardiology · 2011 · 50 citations · Full text

Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease

Talia Weinstein, Avry Chagnac, Mona Boaz et al. · Nephron Clinical Practice · 2004 · 49 citations

Vaccination, Vaccine Development, Hepatology +13